Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Biomedical Nanotechnology

• Publication date

  2015-12-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1166/JBN.2015.2156PMID 26510313PMCID PMC5344192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle

  2014cited by this paper
• In Vitro and in Vivo Evaluation of Lactoferrin-Conjugated Liposomes as a Novel Carrier to Improve the Brain Delivery

  2013cited by this paper
• AAV-Directed Persistent Expression of a Gene Encoding Anti-Nicotine Antibody for Smoking Cessation

  2012cited by this paper
• Effects of adjuvants on IgG subclasses elicited by virus-like Particles

  2012cited by this paper
• PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.

  2012cited by this paper
• Genetic Variation Determines Mast Cell Functions in Experimental Asthma

  2011cited by this paper
• Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3'-deoxy-3'-fluoro-Thomsen-Friedenreich antigen.

  2011cited by this paper
• Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.

  2011cited by this paper
• Pharmacotherapy for smoking cessation: present and future.

  2011cited by this paper
• Effects of 15d‐PGJ2‐loaded poly(D,L‐lactide‐co‐glycolide) nanocapsules on inflammation

  2011cited by this paper
• Assembly of single-walled carbon nanohorn supported liposome particles.

  2011cited by this paper
• Morphological study of acoustic liposomes using transmission electron microscopy.

  2010cited by this paper
• Adverse Effects and Tolerability of Medications for the Treatment of Tobacco Use and Dependence

  2010cited by this paper
• A Facile High-speed Vibration Milling Method to Water-disperse Single-walled Carbon Nanohorns

  2010cited by this paper
• IgG Subclass Profiles in Infected HIV Type 1 Controllers and Chronic Progressors and in Uninfected Recipients of Env Vaccines

  2010cited by this paper
• Stimuli-responsive liposome fusion mediated by gold nanoparticles.

  2010cited by this paper
• Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure.

  2010cited by this paper
• Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure.

  2010cited by this paper
• High-concentration zeta potential measurements using light-scattering techniques

  2010cited by this paper
• In vitro and in vivo studies of single-walled carbon nanohorns with encapsulated metallofullerenes and exohedrally functionalized quantum dots.

  2010cited by this paper
• Vaccines against nicotine

  2009cited by this paper
• Effect of nicotine administration on weight and histology of some vital visceral organs in female albino rats.

  2009cited by this paper
• Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence.

  2009cited by this paper
• Evaluation of albumin microspheres as oral delivery system for Mycobacterium tuberculosis vaccines

  2009cited by this paper
• A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial

  2008cited by this paper
• Toxicity of single-walled carbon nanohorns.

  2008cited by this paper
• Assessing the pulmonary toxicity of single-walled carbon nanohorns

  2007cited by this paper
• Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.

  2007cited by this paper
• Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.

  2007cited by this paper
• A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

  2007cited by this paper
• Guidelines for the Care and Use of Laboratory Animals

  2007cited by this paper
• In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation.

  2006cited by this paper
• How to stabilize phospholipid liposomes (using nanoparticles).

  2006cited by this paper
• Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.

  2006cited by this paper
• Annex 1 WHO guidelines on nonclinical evaluation of vaccines

  2005cited by this paper
• In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles.

  2005cited by this paper
• A guide to deciphering the internal codes used by the tobacco industry

  2005cited by this paper
• Cationic Liposomes Containing Mycobacterial Lipids: a New Powerful Th1 Adjuvant System

  2005cited by this paper
• A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity

  2005cited by this paper
• Sex differences in nicotine's effects on consummatory behavior and body weight in rats

  2004cited by this paper
• Aluminium adjuvants--in retrospect and prospect.

  2004cited by this paper
• Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses.

  2004cited by this paper
• Novel Approaches to Vaccine Delivery

  2004cited by this paper
• Liposomal delivery of antigen to human dendritic cells.

  2003cited by this paper
• A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.

  2002cited by this paper
• Pharmaceutical design of the liposomal antimicrobial agents for infectious disease.

  2002cited by this paper
• Effect of liposomal antigens on the priming and activation of the immune system by dendritic cells.

  2002cited by this paper
• Aluminum salts in vaccines--US perspective.

  2002cited by this paper
• Selective Production of Single-Wall Carbon Nanohorn Aggregates and Their Formation Mechanism

  2002cited by this paper
• Liposomal Delivery of CTL Epitopes to Dendritic Cells

  2002cited by this paper
• Antibody conjugation methods for active targeting of liposomes.

  2000cited by this paper
• Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro.

  2000cited by this paper
• Degradation of phosphatidylcholine in liposomes containing carboplatin in dependence on composition and storage conditions.

  2000cited by this paper
• Cationic microparticles: A potent delivery system for DNA vaccines.

  2000cited by this paper
• Nano-aggregates of single-walled graphitic carbon nano-horns

  1999cited by this paper
• Food and Drug Administration Proposed Testing Guidelines for Developmental Toxicity Studies

  1999cited by this paper
• Food and Drug Administration proposed testing guidelines for developmental toxicity studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.

  1999cited by this paper
• Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties.

  1997cited by this paper
• Equilibrium vesicles: fact or fiction?

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• 3-(2-pyridyldithio)propionic acid hydrazide as a cross-linker in the formation of liposome-antibody conjugates.

  1996cited by this paper
• Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides

  1995cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization

  1994cited by this paper
• Nicotine replacement: effects of postcessation weight gain.

  1989cited by this paper
• Persistent Subcutaneous Nodules in Children Hyposensitized with Aluminium‐Containing Allergen Extracts

  1985cited by this paper
• Effects of nicotine on weight change and food consumption in rats.

  1983cited by this paper
• Histopathological Studies of Reactions in Mice Injected with Aluminum‐Adsorbed Tetanus Toxoid

  1982cited by this paper
• Addition of sulfhydryl groups to Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate).

  1978cited by this paper
• Aluminium hydroxide granuloma.

  1971cited by this paper
• The health consequences of smoking.

  1970cited by this paper
• Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of Infants

  1969cited by this paper
• Spontaneous calcification in hearts of DBA mice

  1969cited by this paper
• Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

  1966cited by this paper
• STUDIES ON ANTIBODY PRODUCTION

  1955cited by this paper
• Organ weights and histology of chronically thiamine-deficient rats and their pair-fed controls.

  1953cited by this paper

• Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction.

  2025cites this paper
• Immunotherapies for the Treatment of Drug Addiction

  2022cites this paper
• Formulation of Nanovaccines toward an Extended Immunity against Nicotine.

  2021cites this paper
• Immune to addiction: how immunotherapies can be used to combat methamphetamine addiction

  2021cites this paper
• Intra-Articular Injection of a Nanosuspension of Tetramethylpyrazine Dihydroxynaphthalenate for Stronger and Longer-Lasting Effects Against Osteoarthritis.

  2021cites this paper
• Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine.

  2021cites this paper
• Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity.

  2020cites this paper
• Intranasal delivery of a nicotine vaccine candidate induces antibodies in mouse blood and lung mucosal secretions that specifically neutralize nicotine

  2020cites this paper
• Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.

  2020cites this paper
• Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface.

  2020cites this paper
• Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine.

  2019cites this paper
• Nanoparticle systems for cancer vaccine.

  2019cites this paper
• Development of vaccines to treat opioid use disorders and reduce incidence of overdose.

  2019cites this paper
• Nanocarbons for Biology and Medicine: Sensing, Imaging, and Drug Delivery.

  2019cites this paper
• Nicotine Vaccines: The Past, the Present, and the Future

  2019cites this paper
• Carbon nanohorn/liposome systems: Preformulation, design and in vitro toxicity studies.

  2019cites this paper
• Vaccines for substance abuse treatment: new approaches in the immunotherapy of addictions

  2018cites this paper
• Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose

  2018cites this paper
• Liposome: composition, characterisation, preparation, and recent innovation in clinical applications

  2018cites this paper
• Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines.

  2018cites this paper
• Estado actual de las vacunas contra la nicotina: una revisión narrativa

  2018cites this paper
• Current status of nicotine vaccines: A narrative review

  2018cites this paper
• Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins.

  2018cites this paper
• Factors that Affect the Immunogenicity of Lipid-PLGA Nanoparticle-Based Nanovaccines against Nicotine Addiction

  2017cites this paper
• Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization.

  2017cites this paper
• Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.

  2017cites this paper
• Current status and future prospects for the development of substance abuse vaccines

  2017cites this paper
• Novel phosphomolybdic acid/single-walled carbon nanohorn-based modified electrode for non-enzyme glucose sensing

  2017cites this paper
• A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy.

  2017cites this paper
• The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine.

  2016cites this paper
• Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes

  2016cites this paper
• Biologics to treat substance use disorders: Current status and new directions

  2016cites this paper
• A simple physiologically based pharmacokinetic model evaluating the effect of anti-nicotine antibodies on nicotine disposition in the brains of rats and humans.

  2016cites this paper
• Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.

  2015cites this paper
• Iron Liposome: A more Effective Iron Supplement for Sports Anemia andAnemia of Inflammation

  2015cites this paper
• Review Paper An Overview of Nicotine Vaccines

  year unknowncites this paper